Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Substituted Glycine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1091097C details a safe, high-purity route for N-substituted glycine esters, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel patent CN103992241A offers high-purity N-substituted phenyl glycine via hydrogenation. Reduces cost and improves supply chain reliability for anticoagulant intermediates.